Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Cameroon

被引：0
|
作者：
Nkengafac, A. D. [1 ]
Tina, S. [1 ]
Sua, F. [1 ]
Mason, T. [1 ]
Auyuketta, N. [1 ]
Oben, S. [1 ]
机构：
[1] Inst Adv Med Sci, Buea, Cameroon
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [21] HIV-1 molecular epidemiology among newly diagnosed HIV-1 individuals in Hebei, a low HIV prevalence province in China
    Lu, Xinli
    Kang, Xianjiang
    Liu, Yongjian
    Cui, Ze
    Guo, Wei
    Zhao, Cuiying
    Li, Yan
    Chen, Suliang
    Li, Jingyun
    Zhang, Yuqi
    Zhao, Hongru
    PLOS ONE, 2017, 12 (02):
  • [22] Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection
    Biagetti, Carlo
    Bon, Isabella
    Vitone, Francesca
    Schiavone, Pasqua
    Borderi, Marco
    Pavoni, Michele
    Verucchi, Gabriella
    Re, Maria Carla
    Chiodo, Francesco
    NEW MICROBIOLOGICA, 2009, 32 (02): : 129 - 134
  • [23] Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India
    Azam, Mohd
    Malik, Abida
    Rizvi, Meher
    Rai, Arvind
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (01): : 79 - 85
  • [24] Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease
    Zhang, Tian-hao
    Dai, Lei
    Barton, John P.
    Du, Yushen
    Tan, Yuxiang
    Pang, Wenwen
    Chakraborty, Arup K.
    Lloyd-Smith, James O.
    Sun, Ren
    PLOS GENETICS, 2020, 16 (10):
  • [25] HIV-1 drug resistance-associated mutations among antiretroviral-na ve Thai patients with chronic HIV-1 infection
    Manosuthi, W.
    Thongyen, S.
    Nilkamhang, S.
    Manosuthi, S.
    Sungkanuparph, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 140 - 140
  • [26] Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations
    Devereux, HL
    Emery, VC
    Johnson, MA
    Loveday, C
    JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (02) : 218 - 224
  • [27] Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan
    Gatanaga, Hiroyuki
    Ibe, Shiro
    Matsuda, Masakazu
    Yoshida, Shigeru
    Asagi, Tsukasa
    Kondo, Makiko
    Sadamasu, Kenji
    Tsukada, Hiroki
    Masakane, Aki
    Mori, Haruyo
    Takata, Noboru
    Minami, Rumi
    Tateyama, Masao
    Koike, Takao
    Itoh, Toshihiro
    Imai, Mitsunobu
    Nagashima, Mami
    Gejyo, Fumitake
    Ueda, Mikio
    Hamaguchi, Motohiro
    Kojima, Yoko
    Shirasaka, Takuma
    Kimura, Akiro
    Yamamoto, Masahiro
    Fujita, Jiro
    Oka, Shinichi
    Sugiura, Wataru
    ANTIVIRAL RESEARCH, 2007, 75 (01) : 75 - 82
  • [28] Prevalence of HIV-1 drug resistance in HIV-1-infected patients treated in Douala, Cameroon
    Charpentier, C.
    Talla, F.
    Joko, A.
    Si-Mohamed, A.
    Belec, L.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A191 - A191
  • [29] HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon
    Mikasi, Sello Given
    Gichana, Josiah Otwoma
    Van der Walt, Cheri
    Brado, Dominik
    Obasa, Adetayo Emmanuel
    Njenda, Duncan
    Messembe, Martha
    Lyonga, Emilia
    Assoumou, Okomo
    Cloete, Ruben
    Ikomey, George Mondinde
    Jacobs, Graeme Brendon
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2020, 36 (05) : 450 - 455
  • [30] Distribution of surveillance drug resistance mutations in different HIV-1 subtypes in newly-diagnosed untreated HIV patients in Croatia
    Grgic, I.
    Vrakela, I. B.
    Gorenec, L.
    Planinic, A.
    Lepej, S. Z.
    ANTIVIRAL THERAPY, 2011, 16 : A152 - A152
12345